| Cat. No. |
Product |
Quantity/Size |
Price |
Data |
|
| RXX00303B |
Anti-Clostridioides difficile Toxin B/tcdB (PA41) mAb |
1mg |
$2,135.00
|
 |
BUY
|
| RXX00303A |
Anti-Clostridioides difficile Toxin B/tcdB (PA41) mAb |
100µg |
$475.00
|
|
BUY
|
| RHJ51403B |
Anti-Mouse ANGPTL4 (6G11) mAb |
1mg |
$1,710.00
|
|
BUY
|
| RHJ51403A |
Anti-Mouse ANGPTL4 (6G11) mAb |
100µg |
$390.00
|
|
BUY
|
| RRJ12901A |
Anti-Rat ARC Nanobody (SAA1466) mAb |
100 µg |
$475.00
|
|
BUY
|
| RRJ12901B |
Anti-Rat ARC Nanobody (SAA1466) mAb |
1.0 mg |
$2,155.00
|
|
BUY
|
| RVV00201A |
Anti-SARS-CoV-2 Spike-NTD (4A8) Neutralizing mAb |
100µg |
$390.00
|
|
BUY
|
| RVV00201B |
Anti-SARS-CoV-2 Spike-NTD (4A8) Neutralizing mAb |
1mg |
$1,710.00
|
|
BUY
|
| CSI12348 |
Armenian Hamster Anti-Mouse TNF-alpha (Clone TN3-19.12) mAb |
1.0 mg |
$595.00
|
|
BUY
|
| CMI245 |
Hamster Anti-Mouse Interleukin-9 (Clone D9302C12) mAb |
0.5 mg |
$820.00
|
|
BUY
|
| RVV08610A |
Human Anti-HCV NS1/gp68/gp70/Envelope glycoprotein E2 (HC33.1) mAb |
100 µg |
$475.00
|
|
BUY
|
| RVV08610B |
Human Anti-HCV NS1/gp68/gp70/Envelope glycoprotein E2 (HC33.1) mAb |
1.0 mg |
$2,135.00
|
|
BUY
|
| RVV08005A |
Human Anti-HeV/NiV Glycoprotein G (HENV-1) mAb |
100 µg |
$475.00
|
|
BUY
|
| RVV08005B |
Human Anti-HeV/NiV Glycoprotein G (HENV-1) mAb |
1.0 mg |
$2,135.00
|
|
BUY
|
| RVV08008A |
Human Anti-HeV/NiV Glycoprotein G (HENV-10) mAb |
100 µg |
$475.00
|
|
BUY
|
| RVV08008B |
Human Anti-HeV/NiV Glycoprotein G (HENV-10) mAb |
1.0 mg |
$2,135.00
|
|
BUY
|
| RVV08009B |
Human Anti-HeV/NiV Glycoprotein G (HENV-18) mAb |
1.0 mg |
$2,135.00
|
|
BUY
|
| RVV08009A |
Human Anti-HeV/NiV Glycoprotein G (HENV-18) mAb |
100 µg |
$475.00
|
|
BUY
|
| RVV08006A |
Human Anti-HeV/NiV Glycoprotein G (HENV-2) mAb |
100 µg |
$475.00
|
|
BUY
|
| RVV08006B |
Human Anti-HeV/NiV Glycoprotein G (HENV-2) mAb |
1.0 mg |
$2,135.00
|
|
BUY
|
| RVV08010A |
Human Anti-HeV/NiV Glycoprotein G (HENV-21) mAb |
100 µg |
$475.00
|
|
BUY
|
| RVV08010B |
Human Anti-HeV/NiV Glycoprotein G (HENV-21) mAb |
1.0 mg |
$2,135.00
|
|
BUY
|
| RVV08011A |
Human Anti-HeV/NiV Glycoprotein G (HENV-43) mAb |
100 µg |
$475.00
|
|
BUY
|
| RVV08011B |
Human Anti-HeV/NiV Glycoprotein G (HENV-43) mAb |
1.0 mg |
$2,135.00
|
|
BUY
|
| RVV08007B |
Human Anti-HeV/NiV Glycoprotein G (HENV-9) mAb |
1.0 mg |
$2,135.00
|
|
BUY
|
| RVV08007A |
Human Anti-HeV/NiV Glycoprotein G (HENV-9) mAb |
100 µg |
$475.00
|
|
BUY
|
| RVV22902B |
Human Anti-HMPV F/Fusion Protein Antibody (DS7) |
1.0 mg |
$1,940.00
|
|
BUY
|
| RVV22902A |
Human Anti-HMPV F/Fusion Protein Antibody (DS7) |
100µg |
$440.00
|
|
BUY
|
| RVV08808A |
Human Anti-HPV16 L1/Major capsid protein L1 (H16.14J) mAb |
100 µg |
$475.00
|
|
BUY
|
| RVV08808B |
Human Anti-HPV16 L1/Major capsid protein L1 (H16.14J) mAb |
1.0 mg |
$2,135.00
|
|
BUY
|
| RVV08804B |
Human Anti-HPV16 L1/Major capsid protein L1 (H16.U4) mAb |
1.0 mg |
$2,135.00
|
|
BUY
|
| RVV08804A |
Human Anti-HPV16 L1/Major capsid protein L1 (H16.U4) mAb |
100 µg |
$475.00
|
|
BUY
|
| RVV02809B |
Human Anti-HRSV-A F/Fusion glycoprotein F0 (D25) mAb |
1.0 mg |
$2,135.00
|
|
BUY
|
| RVV02809A |
Human Anti-HRSV-A F/Fusion glycoprotein F0 (D25) mAb |
100 µg |
$475.00
|
|
BUY
|
| RVV04315B |
Human Anti-LASV GPC (37.7F) mAb |
1.0 mg |
$2,135.00
|
|
BUY
|
| RVV04315A |
Human Anti-LASV GPC (37.7F) mAb |
100 µg |
$475.00
|
|
BUY
|
| RVV07503A |
Human Anti-MERS-CoV RBD (CDC2-C2) mAb |
100µg |
$440.00
|
|
BUY
|
| RVV07503B |
Human Anti-MERS-CoV RBD (CDC2-C2) mAb |
1mg |
$1,940.00
|
|
BUY
|
| CPC534B |
Human Anti-SARS-CoV-2 Spike-RBD Bamlanivimab (LY-CoV555）Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC534A |
Human Anti-SARS-CoV-2 Spike-RBD Bamlanivimab (LY-CoV555）Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC538A |
Human Anti-SARS-CoV-2 (2019-nCoV) Spike Glycoprotein Sotrovimab (VIR-7831 / GSK4182136) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC538B |
Human Anti-SARS-CoV-2 (2019-nCoV) Spike Glycoprotein Sotrovimab (VIR-7831 / GSK4182136) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC524A |
Human Anti-SARS-CoV-2 (2019-nCoV) Spike S1 Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC524B |
Human Anti-SARS-CoV-2 (2019-nCoV) Spike S1 Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC535B |
Human Anti-SARS-CoV-2 (2019-nCoV) Spike-RBD Cilgavimab (AZD1061) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC535A |
Human Anti-SARS-CoV-2 (2019-nCoV) Spike-RBD Cilgavimab (AZD1061) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC537A |
Human Anti-SARS-CoV-2 (2019-nCoV) Spike-RBD Tixagevimab (AZD8895) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC537B |
Human Anti-SARS-CoV-2 (2019-nCoV) Spike-RBD Tixagevimab (AZD8895) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC523B |
Human Anti-SARS-CoV-2 Spike RBD (B38) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC522B |
Human Anti-SARS-CoV-2 Spike RBD (B38) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC523A |
Human Anti-SARS-CoV-2 Spike RBD (B38) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC522A |
Human Anti-SARS-CoV-2 Spike RBD (B38) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC521B |
Human Anti-SARS-CoV-2 Spike RBD (H4) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC521A |
Human Anti-SARS-CoV-2 Spike RBD (H4) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC520A |
Human Anti-SARS-CoV-2 Spike S1 (CR3022) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC520B |
Human Anti-SARS-CoV-2 Spike S1 (CR3022) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC514B |
Human Anti-SARS-CoV-2 Spike-NTD (4A8) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC514C |
Human Anti-SARS-CoV-2 Spike-NTD (4A8) Neutralizing mAb |
1.0 mg |
Please Inquire |
|
BUY
|
| CPC542C |
Human Anti-SARS-CoV-2 Spike-RBD (002-S21F2) Broad-Neutralizing mAb |
1.0 mg |
Please Inquire |
|
BUY
|
| CPC526A |
Human Anti-SARS-CoV-2 Spike-RBD (Clone AbG123) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC526B |
Human Anti-SARS-CoV-2 Spike-RBD (Clone AbG123) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC510A |
Human Anti-SARS-CoV-2 Spike-RBD (Clone VHH-72-Fc) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC510B |
Human Anti-SARS-CoV-2 Spike-RBD (Clone VHH-72-Fc) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC513A |
Human Anti-SARS-CoV-2 Spike-RBD (EY6A) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC513B |
Human Anti-SARS-CoV-2 Spike-RBD (EY6A) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC525A |
Human Anti-SARS-CoV-2 Spike-RBD (S309) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC525B |
Human Anti-SARS-CoV-2 Spike-RBD (S309) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC539B |
Human Anti-SARS-CoV-2 Spike-RBD Bebtelovimab (LY-CoV1404 / LY3853113) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC539C |
Human Anti-SARS-CoV-2 Spike-RBD Bebtelovimab (LY-CoV1404 / LY3853113) Neutralizing mAb |
1.0 mg |
Please Inquire |
|
BUY
|
| CPC539A |
Human Anti-SARS-CoV-2 Spike-RBD Bebtelovimab (LY-CoV1404 / LY3853113) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC511A |
Human Anti-SARS-CoV-2 Spike-RBD Casirivimab(REGN10933) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC511B |
Human Anti-SARS-CoV-2 Spike-RBD Casirivimab(REGN10933) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC516A |
Human Anti-SARS-CoV-2 Spike-RBD Etesevimab (CB6, JS016, LY-CoV-016) Neutralizing mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC516B |
Human Anti-SARS-CoV-2 Spike-RBD Etesevimab (CB6, JS016, LY-CoV-016) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC512B |
Human Anti-SARS-CoV-2 Spike-RBD Imdevimab (REGN10987) Neutralizing mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC541A |
Human Anti-SARS-CoV-2 Spike-RBD Neutralizing (S2E12) mAb |
50 µg |
Please Inquire |
|
BUY
|
| CPC541B |
Human Anti-SARS-CoV-2 Spike-RBD Neutralizing (S2E12) mAb |
100 µg |
Please Inquire |
|
BUY
|
| CPC541C |
Human Anti-SARS-CoV-2 Spike-RBD Neutralizing (S2E12) mAb |
1.0 mg |
Please Inquire |
|
BUY
|
| CMA006A |
Human anti-TNF alpha (Clone D2E7) Adalimumab |
200 μg |
$690.00
|
|
BUY
|
| CMA006B |
Human anti-TNF alpha (Clone D2E7) Adalimumab |
1.0 mg |
$2,900.00
|
|
BUY
|
| RVV14103A |
Human Anti-Vaccinia virus/VACV Protein A27 (Clone 186#) mAb |
100 µg |
$475.00
|
|
BUY
|
| RVV14103B |
Human Anti-Vaccinia virus/VACV Protein A27 (Clone 186#) mAb |
1.0 mg |
$2,135.00
|
|
BUY
|
| RVV14104A |
Human Anti-Vaccinia virus/VACV Protein A27 (Clone 188#) mAb |
100 µg |
$475.00
|
|
BUY
|
| RVV14104B |
Human Anti-Vaccinia virus/VACV Protein A27 (Clone 188#) mAb |
1.0 mg |
$2,135.00
|
|
BUY
|
| RVV14102A |
Human Anti-Vaccinia virus/VACV Protein A27 (Clone 1G6) mAb |
100 µg |
$475.00
|
|
BUY
|
| RVV14102B |
Human Anti-Vaccinia virus/VACV Protein A27 (Clone 1G6) mAb |
1.0 mg |
$2,135.00
|
|
BUY
|
| RVV14105B |
Human Anti-Vaccinia virus/VACV Protein A27 (Clone 203#) mAb |
1.0 mg |
$2,135.00
|
|
BUY
|
| RVV14105A |
Human Anti-Vaccinia virus/VACV Protein A27 (Clone 203#) mAb |
100 µg |
$475.00
|
|
BUY
|
| VVV00504A |
InVivo Mab Anti-SARS-CoV-2 S2/Spike glycoprotein 2 (28D9) |
100 µg |
$475.00
|
|
BUY
|
| VVV00504B |
InVivo Mab Anti-SARS-CoV-2 S2/Spike glycoprotein 2 (28D9) |
1 mg |
$1,670.00
|
|
BUY
|
| VVV25001A |
InVivoMAb Anti-BRSV G/Major surface glycoprotein G (B4) |
100 µg |
$475.00
|
|
BUY
|
| VVV25001B |
InVivoMAb Anti-BRSV G/Major surface glycoprotein G (B4) |
1 mg |
$1,670.00
|
|
BUY
|
| VQJ05001B |
InVivoMAb Anti-Dog IL31 (Iv0213) |
1 mg |
$1,670.00
|
|
BUY
|
| VQJ05001A |
InVivoMAb Anti-Dog IL31 (Iv0213) |
100 µg |
$475.00
|
|
BUY
|
| VQJ05002B |
InVivoMAb Anti-Dog IL31 (Iv0214) |
1 mg |
$1,670.00
|
|
BUY
|
| VQJ05002A |
InVivoMAb Anti-Dog IL31 (Iv0214) |
100 µg |
$475.00
|
|
BUY
|
| VVV22001B |
InVivoMAb Anti-EBV/HHV4 gB/BALF4 (Iv0133) |
1 mg |
$1,715.00
|
|
BUY
|
| VVV22001A |
InVivoMAb Anti-EBV/HHV4 gB/BALF4 (Iv0133) |
100 µg |
$475.00
|
|
BUY
|
| VVV22002B |
InVivoMAb Anti-EBV/HHV4 gB/BALF4 (Iv0134) |
1 mg |
$1,715.00
|
|
BUY
|
| VVV22002A |
InVivoMAb Anti-EBV/HHV4 gB/BALF4 (Iv0134) |
100 µg |
$475.00
|
|
BUY
|
